Skip to main content
. 2010 Mar 26;21(10):2107–2111. doi: 10.1093/annonc/mdq078

Figure 2.

Figure 2.

Survival probability by additional malignancy grouping. Patients with GIST alone appeared to have a trend toward the best overall survival (group III). Patients with GIST and two or more cancers were found to have a statistically significant inferior overall survival (P = 0.007). Patients with GIST as the first malignancy and a subsequent tumor (group I) and patients with another malignancy in their history (group II) had an intermediate survival compared with groups III and IV. GIST, gastrointestinal stromal tumor.